Multiple therapies (locoregional therapies plus anti-VEGF/TKIs and immune checkpoint inhibitors)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Multiple therapies (locoregional therapies plus anti-VEGF/TKIs and immune checkpoint inhibitors), covering 2026-01-26 to 2026-01-26. Get the full timeline:
Most recent: Clinical Trial Update: A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma